38TH ANNUAL CONFERENCE OF THE CANADIAN SOCIETY OF CLINICAL CHEMISTS approach involves performing an initial screening test, the results of which are used to decide whether further tests are performed. All protocols received endorsement from the Medical Staff prior to implementation and physicians ca
β¦ LIBER β¦
A new clinically useful immunosuppressive drug, bredinin
β Scribed by H. Ishikawa; M. Tsujino; K. Mizuno; J. Murase; K. Hayano; T. Watanabe; J. Abe
- Publisher
- Elsevier Science
- Year
- 1980
- Tongue
- English
- Weight
- 84 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0192-0561
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Distribution of a new immunosuppressive
β
L. Langman; D. LeGatt; R. Yatscoff
π
Article
π
1994
π
Elsevier Science
π
English
β 114 KB
ChemInform Abstract: Synthesis of Sugar-
β
Satoshi Shuto; Kimiyo Haramuishi; Masayoshi Fukuoka; Akira Matsuda
π
Article
π
2001
π
John Wiley and Sons
β 33 KB
Drug interactions in a clinic using COST
β
Mark R. Dambro; Mark A. Kallgren
π
Article
π
1988
π
Elsevier Science
π
English
β 691 KB
Clinical evaluation of benzbromarone. A
β
Leif B. Sorensen; Dennis J. Levinson
π
Article
π
1976
π
John Wiley and Sons
π
English
β 557 KB
Donor cell chimerism permitted by immuno
β
Thomas E. Starlz; Anthony J. Demetris; Noriko Murase; Angus W. Thomson; Massimo
π
Article
π
1993
π
Elsevier Science
π
English
β 930 KB
Development and clinical use of the new
β
AndrΓ© Reyntjens; Marleen Verlinden; Tonny Aerts
π
Article
π
1986
π
John Wiley and Sons
π
English
β 730 KB
Cisapride is a new gastrointestinal prokinetic substance that is devoid of antidopaminergic and direct muscarinic activity. This was evidenced by a lack of effect on prolactin release and gastric secretion. In man, cisapride stimulates lower esophageal, gastric, small intestinal, and colonic motilit